ADMA BIOLOGICS, INC. (ADMA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, ADMA BIOLOGICS, INC. reported revenue of $510.17M, up 19.6% from the prior year. The company was profitable, with a net margin of 28.8% and a gross margin of 57.4%. It held $624.24M in total assets against $146.92M in total liabilities.
Key ratios (FY2025)
57.4%
Gross margin
37.5%
Operating margin
28.8%
Net margin
30.8%
Return on equity
+19.6%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $510.17M | $426.45M | $258.21M | $154.08M | $80.94M | $42.22M | — | — | — | — |
| Cost of Revenue | $217.41M | $206.90M | $169.27M | $118.81M | $79.77M | $61.29M | $39.50M | $42.19M | $29.16M | $1.61M |
| Gross Profit | $292.76M | $219.55M | $88.94M | $35.27M | $1.17M | -$19.07M | — | -$25.21M | -$6.40M | $4.30M |
| Operating Income | $191.44M | $138.98M | $21.63M | -$39.37M | -$58.37M | -$64.91M | -$41.42M | -$60.29M | -$39.31M | -$17.33M |
| Net Income | $146.93M | $197.67M | -$28.24M | -$65.90M | -$71.65M | -$75.75M | -$48.28M | -$65.74M | -$43.76M | -$19.52M |
| EPS (Diluted) | $0.60 | $0.81 | $-0.13 | $-0.33 | $-0.51 | $-0.88 | — | — | — | — |
| Total Assets | $624.24M | $488.68M | $329.18M | $348.46M | $276.25M | $207.67M | $127.09M | $88.88M | $108.02M | $23.69M |
| Total Liabilities | $146.92M | $139.66M | $193.98M | $196.49M | $135.08M | $119.42M | $100.90M | $69.11M | $67.69M | $28.14M |
| Shareholders' Equity | $477.32M | $349.02M | $135.21M | $151.97M | $141.17M | $88.25M | $26.19M | $19.77M | $40.33M | -$4.46M |
| Cash & Equivalents | $87.63M | $103.15M | $51.35M | $86.52M | $51.09M | $55.92M | $26.75M | $26.75M | $43.11M | $9.91M |
| Operating Cash Flow | $50.40M | $118.67M | $8.80M | -$59.51M | -$112.37M | -$102.00M | -$76.19M | -$62.68M | -$37.27M | -$18.27M |
| Capital Expenditures | $22.57M | $8.23M | $4.77M | $13.91M | $13.51M | $12.73M | $3.81M | $2.10M | $2.68M | $73.4K |
| Shares Outstanding | 237.87M | 236.62M | 226.06M | 221.82M | 195.81M | 104.90M | 59.32M | 46.35M | 36.73M | 12.89M |